Haldol is a Intramuscular Injection in the Human Prescription Drug category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is Haloperidol Lactate.
| Product ID | 50458-255_3ba71ec4-639a-11ea-b9d7-9d1ffc2ca371 |
| NDC | 50458-255 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Haldol |
| Generic Name | Haloperidol |
| Dosage Form | Injection |
| Route of Administration | INTRAMUSCULAR |
| Marketing Start Date | 1971-05-18 |
| Marketing Category | NDA / NDA |
| Application Number | NDA015923 |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | HALOPERIDOL LACTATE |
| Active Ingredient Strength | 5 mg/mL |
| Pharm Classes | Typical Antipsychotic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 1971-05-18 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA015923 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1971-05-18 |
| Ingredient | Strength |
|---|---|
| HALOPERIDOL LACTATE | 5 mg/mL |
| SPL SET ID: | 27cfe684-7d11-4f37-9c8b-b2bdd6b5348e |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 50458-255 | Haldol | Haldol |
| 0121-0581 | Haloperidol | Haloperidol |
| 0378-0214 | Haloperidol | haloperidol |
| 0378-0257 | Haloperidol | haloperidol |
| 0378-0327 | Haloperidol | haloperidol |
| 0378-0334 | Haloperidol | haloperidol |
| 0378-0335 | Haloperidol | haloperidol |
| 0378-0351 | Haloperidol | haloperidol |
| 0615-2594 | Haloperidol | Haloperidol |
| 0615-2595 | Haloperidol | Haloperidol |
| 0615-2596 | Haloperidol | Haloperidol |
| 0615-2597 | Haloperidol | Haloperidol |
| 0404-9871 | Haloperidol Lactate | Haloperidol |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() HALDOL 72192450 0777269 Live/Registered |
McNeil Laboratories, Incorporated 1964-05-01 |